Skip to main content
# Title Department Research Year
41 Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
42 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
43 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
44 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
45 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023
46 Anatase titanium oxide nanoparticles and multi-walled carbon nanotubes-modified carbon paste electrode for simultaneous determination of avanafil and doxorubicin in plasma samples 2023
47 Selective fluorescence turn-on detection of combination cisplatin–etoposide chemotherapy based on N-CDs/GSH-CuNCs nanoprobe† Department of Pharmaceutical Analytical Chemistry 2023
48 Combined Experimental/Computational Aspects for the Molecular Interaction of Empagliflozin with Bovine Serum Albumin: Quantification, and Application to Human Plasma Department of Pharmaceutical Analytical Chemistry 2023
49 Synthesis and characterization of magnetic Ag–Fe3O4@polymer hybrid nanocomposite systems with promising antibacterial application Department of Industrial Pharmacy 2023
50 Design, synthesis, and antiproliferative properties of new 1, 2, 3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2023